- Home
- PCRX vs PMT Comparison
PCRX vs PMT Comparison
Compare PCRX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- PMT
- Stock Information
- Founded
- PCRX 2006
- PMT 2009
- Country
- PCRX United States
- PMT United States
- Employees
- PCRX N/A
- PMT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- PMT Real Estate Investment Trusts
- Sector
- PCRX Health Care
- PMT Real Estate
- Exchange
- PCRX Nasdaq
- PMT Nasdaq
- Market Cap
- PCRX 1.1B
- PMT 1.1B
- IPO Year
- PCRX 2011
- PMT 2009
- Fundamental
- Price
- PCRX $24.65
- PMT $12.99
- Analyst Decision
- PCRX Buy
- PMT Buy
- Analyst Count
- PCRX 9
- PMT 7
- Target Price
- PCRX $30.11
- PMT $14.93
- AVG Volume (30 Days)
- PCRX 1.2M
- PMT 1.1M
- Earning Date
- PCRX 05-06-2025
- PMT 04-22-2025
- Dividend Yield
- PCRX N/A
- PMT 12.32%
- EPS Growth
- PCRX N/A
- PMT N/A
- EPS
- PCRX N/A
- PMT 1.37
- Revenue
- PCRX $700,966,000.00
- PMT $504,603,000.00
- Revenue This Year
- PCRX $9.48
- PMT N/A
- Revenue Next Year
- PCRX $11.31
- PMT $0.87
- P/E Ratio
- PCRX N/A
- PMT $9.50
- Revenue Growth
- PCRX 3.85
- PMT N/A
- 52 Week Low
- PCRX $11.16
- PMT $11.77
- 52 Week High
- PCRX $31.67
- PMT $15.22
- Technical
- Relative Strength Index (RSI)
- PCRX 51.22
- PMT 41.41
- Support Level
- PCRX $24.10
- PMT $11.81
- Resistance Level
- PCRX $25.35
- PMT $14.87
- Average True Range (ATR)
- PCRX 1.49
- PMT 0.56
- MACD
- PCRX 0.01
- PMT -0.13
- Stochastic Oscillator
- PCRX 48.89
- PMT 38.56
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.